National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Chronic Myeloproliferative Disorders Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 08/01/2008



General Information About Chronic Myeloproliferative Disorders






Chronic Myelogenous Leukemia






Polycythemia Vera






Chronic Idiopathic Myelofibrosis






Essential Thrombocythemia






Chronic Neutrophilic Leukemia






Chronic Eosinophilic Leukemia






Stages of Chronic Myeloproliferative Disorders






Treatment Option Overview






Treatment Options for Chronic Myeloproliferative Disorders






To Learn More About Chronic Myeloproliferative Disorders






Get More Information From NCI






Changes to This Summary (08/01/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
To Learn More About Chronic Myeloproliferative Disorders

For more information from the National Cancer Institute about chronic myeloproliferative disorders, see the following:

For general cancer information and other resources from the National Cancer Institute, see the following:

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov